Next-Generation 3D Scaffolds for Nano-Based Chemotherapeutics Delivery and Cancer Treatment.
S M Shatil ShahriarSyed Muntazir AndrabiFarhana IslamJeong Man AnSamantha J SchindlerMitchell P MatisDong Yun LeeYong-Kyu LeePublished in: Pharmaceutics (2022)
Cancer is the leading cause of death after cardiovascular disease. Despite significant advances in cancer research over the past few decades, it is almost impossible to cure end-stage cancer patients and bring them to remission. Adverse effects of chemotherapy are mainly caused by the accumulation of chemotherapeutic agents in normal tissues, and drug resistance hinders the potential therapeutic effects and curing of this disease. New drug formulations need to be developed to overcome these problems and increase the therapeutic index of chemotherapeutics. As a chemotherapeutic delivery platform, three-dimensional (3D) scaffolds are an up-and-coming option because they can respond to biological factors, modify their properties accordingly, and promote site-specific chemotherapeutic deliveries in a sustainable and controlled release manner. This review paper focuses on the features and applications of the variety of 3D scaffold-based nano-delivery systems that could be used to improve local cancer therapy by selectively delivering chemotherapeutics to the target sites in future.
Keyphrases
- papillary thyroid
- cardiovascular disease
- cancer therapy
- tissue engineering
- squamous cell
- mental health
- type diabetes
- drug delivery
- high throughput
- lymph node metastasis
- childhood cancer
- adverse drug
- metabolic syndrome
- current status
- radiation therapy
- disease activity
- cardiovascular risk factors
- single cell
- drug induced